Safeguard, evaluate and protect cancer patients during the COVID-19 pandemic
A United Kingdom pandemic response
programme for cancer patients
We safeguard cancer patients from coronavirus
The UK Coronavirus Cancer Programme (UKCCP) is one of the longest running and most successful pandemic response programmes for cancer patients. Our mission is to safeguard, evaluate and protect cancer patients during the COVID-19 pandemic through population-scale real world evaluations.
We bring unparalleled expertise and resources from across the United Kingdom to provide the highest quality evaluations required to reduce the risk of coronavirus to cancer patients to population levels.
Our global impact is delivered by over 250 individuals who have contributed from our 86 cancer centres.
A portfolio of the highest quality evaluations
Our projects have demonstrated how to deliver safe cancer care during the pandemic. We have also delivered the scientific evidence for approaches and strategies to maximise patients safety. You can find out about our projects here:
“The ability of this cancer research programme to consistently deliver high impact publication is remarkable. The UKCCP has successfully delivered 13 academic evaluations across 10 research projects since 2020”